Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 127
शीर्षक | मुख्य जाँचकर्ता | शुरुवाती साल | निधीयन एजेंसी | ध्यानाकर्षण क्षेत्र |
---|---|---|---|---|
Therapeutic Significance of MARCKS Signaling Axis in Ovarian Cancer Metastasis: A Precision Anti-Metastatic Therapy Approach | Dr. Purusottam Mohapatra, DBT Ramalingaswami Fellow, National Institute of Pharmaceutical Education and Research (NIPER-G), Guwahati | 2022 | Biotechnology, Ovarian Cancer Metastasis | |
Exercise Imitating microRNA Lipodendriplex for the prevention and treatment of obesity | Prof. Rakesh Kumar Tekade, Associate Professor, National Institute of Pharmaceutical Education and Research, Ahmedabad | 2022 | Pharmaceutics, Genetic Engineering | |
Electro-conductive and immunomodulatory macroporous hydrogel conduit for faster spinal cord regeneration | Dr. Akshay Srivastava, Associate Professor, National Institute of Pharmaceutical Education and Research, Ahmedabad | 2022 | Medical Devices | |
Antipyretic, antimalarial evaluation and formulation development studies of dried fish extracts and fermented fish preparations belonging to the Punitus species | Dr. Chandrajit Dohutia, Pratiksha Institute of Pharmaceutical Sciences, Panikhaiti | 2022 | Antimalarial Evaluation | |
Development of functionalized dual loaded herbal nano-colloidal carrier: Active targeting and repositioning of teriflunomide for synergistically enhancing role of sulphoraphane in combating triple negative breast cancer | Dr. Sushama Talegaonkar, Associate Professor, Delhi Pharmaceutical Sciences and Research University | 2021 | Pharmacology, Toxicology | |
Deciphering the redox chemistry of physical plasma-treated clinically-relevant liquids as novel therapy against ovarian cancer | Dr. Naresh Kumar, Ramalingaswami fellow, National Institute of Pharmaceutical Education and Research (NIPER-G), Guwahati | 2021 | Pharmacology, Toxicology | |
Neutralizing Peptide Antibody Designed for Human Complement Fragment 5a (hC5a) | Dr Soumendra Rana, Assistant Professor, Indian Institute of Technology (IIT) Bhubaneswar | 2020 | Drug repurposing for COVID-19 | |
Development of affordable synthetic route of Re-purposed small molecule drugs for the treatment of SARS-CoV-2 | Dr Parthasarathi Das, Associate Professor, Dr Somnath Yadav, Assistant Professor, Dr Soumitra Maity, Assistant Professor, Indian Institute of Technology (IIT), Dhanbad | 2020 | Drug repurposing for COVID-19 | |
Developing a novel effective therapeutic agent targeting pancreatic Cancer | Dr Ramesh Ummanni, Scientist, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | New molecule development against pancreatic cancer |
In silico screening for repurposing known drugs for SARS-CoV-2 using AI and molecular simulations | Prof. Jayant Kumar Singh, Professor, Indian Institute of Technology (IIT), Kanpur | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | Drug repurposing for COVID-19 |